Aquablation Procedure Safe for BPH, With Durable Efficacy
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, May 31, 2023 -- For men with large prostates, the Aquablation procedure is safe, with durable efficacy, according to a study published online April 28 in The Journal of Urology.
Naeem Bhojani, M.D., from the University of Montreal, and colleagues reported five-year safety and efficacy outcomes of the Aquablation procedure for treatment of symptomatic benign prostatic hyperplasia and large-volume prostate glands. Data were included for 101 men with moderate-to-severe benign prostatic hyperplasia symptoms and prostate volumes between 80 and 150 mL (mean volume at baseline, 107 mL), who underwent a robotic-assisted Aquablation procedure.
The researchers found that the study successfully met its safety and efficacy performance goal at three months, which was based on transurethral resection of the prostate outcomes typically done in smaller prostates. A significant improvement was seen in patient symptoms, with a change of 15.9 in the International Prostate Symptom Score (from 22.6 at baseline to 6.8 at five years). Improvement was also demonstrated in the mean maximum urinary flow rate, from 8.6 to 17.1 mL/s at baseline and five years, respectively (change, 9.2 mL/s). No difference was seen in efficacy outcomes through five years in a prespecified subgroup analysis using a baseline prostate volume cutoff of 100 mL. At five years, freedom from a secondary benign prostatic hyperplasia procedure was 96.3 percent.
"With real-time ultrasound guidance and robotic execution, Aquablation has the potential to treat prostates of nearly any size," the authors write. "The five-year data validate the durability of Aquablation."
Several authors disclosed ties to PROCEPT BioRobotics, which funded the clinical study.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2023
Read this next
GLP1 Receptor Agonists Do Not Up Risk for Complications After Emergency Surgery
THURSDAY, April 25, 2024 -- The risk for postoperative respiratory complications is similar among patients undergoing emergency surgery regardless of preoperative glucagon-like...
Wearable Technology During Surgery Provides Neurosurgeons With Postural Info
WEDNESDAY, April 24, 2024 -- Wearable technology is feasible to assess postural ergonomics and provide objective biofeedback to neurosurgeons, according to a pilot study published...
Knee Osteoarthritis Symptoms Common After ACL Reconstruction
TUESDAY, April 23, 2024 -- Nearly one-quarter of patients show persistent early knee osteoarthritis (OA) symptoms six to 12 months after anterior cruciate ligament reconstruction...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.